https://ichs2018.com/

Dear colleagues:

As the current president of the International Immunocompromised Host Society, I wholeheartedly invite you to support and attend the 20th biennial Congress of the International Immunocompromised Host Society (ICHS 2018) to be held in Athens, Greece, from June 17-19, 2018.  Our 20th international symposium will be held at the Hotel Divani Acropolis, a short distance from the beautiful and historic sites of ancient Athens.

ICHS is the premier, international, multi-disciplinary forum for scientific and clinical interchange to improve understanding and management of the immunocompromised host. It was founded in 1980 by an international, multi-disciplinary group of experts interested in all different aspects of immune deficiencies including inborn errors, treatment-induced or transplant-associated immunosuppression as well as HIV infection and others.

Our biennial symposia have seen attendance of hundreds of delegates from all over the world and included lectures by internationally renowned expert speakers.  The program for the 20th ICHS symposium is scientifically very robust and covers a broad-spectrum of topics across different contexts of immunosuppression and across different pathogens, delivered by the eminent thought leaders in the field of infections in immunosuppressed host. We have featured keynote lectures on microbiome, mega-data, nano-technology, viral causes of cancer. Phillip Pizzo will be our inaugural key note speaker on the topic” “The evolution of infectious disease management in the neutropenic patient: reflection of the last 50 years”.

On behalf of the ICHS council, it will be a great pleasure for us to welcome you as clinical practitioners and researchers to this unique international meeting. We hope to see you in Athens in June 2018!

Best personal regards,

Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), FACP, FIDSA, FECMM, FAAM
Texas  4000 Distinguished Endowed Professor For Cancer Research
Deputy Head, Division of Internal Medicine  
The University of Texas MD Anderson Cancer Center